Migraine, memory loss, and "multiple sclerosis". Neurological features of the antiphospholipid (Hughes') syndrome

Postgraduate Medical Journal

Volumn 79, Issue 928, 2003, Pages 81-83

  Hughes, Graham R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

AMNESIA; ANTIPHOSPHOLIPID SYNDROME; ATAXIA; BEHAVIOR DISORDER; CHOREA; CLINICAL FEATURE; DIPLOPIA; EPILEPSY; HEADACHE; HUMAN; MIGRAINE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPATHY; REVIEW; SPINAL CORD DISEASE; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADULT; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEADACHE DISORDERS; HUMANS; MEMORY DISORDERS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES;

EID: 0037294863     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.79.928.81     Document Type: Review

References (15)

1. Narvarreta MG, Boey RL, Levine SR. Cerebral disease in the antiphospholipid syndrome. In: Khamashta MA, ed. Hughes syndrome: antiphospholipid syndrome. London: Springer-Verlag, 2000: 43-58.
2. Hughes GRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. BMJ 1983;287:1088-9.
3. Khamasha MA. Hughes syndrome: history. In: Khamashta MA, ed. Hughes syndrome: antiphospholipid syndrome. London: Springer-Verlag, 2000: 3-7.
4. Harris EN, Gharavi AE, Asherson RA, et al. Cerebral infarction in systeic lupus. Association with anticardiolipin antibodies. Clin Exp Rheumatol 1984;2:47-51.
5. Cuadrado MJ, Khamashta MA, Hughes GRV. Sticky blood and headache. Lupus 2001;10:392-3.
6. Cuadrado MJ, Khamashta MA, Hughes GRV. Migraine and stroke in young women. QJ Med 2002;93:317-19.
7. Hughes GRV. Off the beaten track: a clinician's view. In: Khamashta MA, ed. Hughes syndrome: the antiphospholipid syndrome. London: Springer-Verlag, 2000:105-10.
8. Mackworth-Young CG, Hughes GRV. Epilepsy: an early symptom of SLE. J Neurol Neurosurg Psychiatry 1985;48:185.
9. Peltola JT, Haapala A, Isojarvi JI, et al. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am J Med 2000;109:712-17.
10. Blank M, Krause I, Shoenfeld Y.The contribution of experimental models to our understanding of etiology, pathogenesis and novel therapies in the antiphospholipid syndrome. In: Khamashta MA, ed. Hughes syndrome: antiphospholipid syndrome. London: Springer-Verlag, 2000:379-90.
11. Cuadrado MJ, Khamashta MA, Ballesteros A, et al. Can Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2002;79:57-68.
12. Shah MN, Khamashta MA, Atsumi T, et al. Outcome of patients with anticardiolipin antibodies: a ten year follow-up of 52 patients. Lupus 1998;7:3-6.
13. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;332:993-7.
14. Cuadrado MJ, Khamashta MA, D'Cruz D, et al. Migraine in Hughes syndrome - heparin as a therapeutic trial. Q J Med 2001;94:114-15.
15. Bertolaccini ML, Atsumi T, Escudero A, et al. The value of IgA antiphospholipid testing for the diagnosis of antiphospholipid (Hughes) syndrome in SLE. J Rheumatol 2001;28:2637-43.